
HSTO
Healthcare · Biotechnology · $85,435 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 9, 2023 | After the close | -0.54 | -0.90 | -66.7% |
| Aug 10, 2023 | After the close | -0.90 | -0.49 | +45.6% |
| May 11, 2023 | After the close | -0.76 | -0.81 | -6.6% |
| Mar 9, 2023 | After the close | -0.79 | -0.61 | +22.8% |
| Nov 10, 2022 | After the close | -1.26 | -1.01 | +19.8% |
| Aug 11, 2022 | After the close | -1.70 | -1.55 | +8.8% |
| May 12, 2022 | After the close | -1.50 | -0.20 | +86.7% |
| Mar 10, 2022 | After the close | -2.10 | -1.40 | +33.3% |
| Nov 10, 2021 | After the close | -2.30 | -1.80 | +21.7% |
| Aug 11, 2021 | After the close | -3.40 | -2.00 | +41.2% |
| May 13, 2021 | After the close | -3.00 | -2.80 | +6.7% |
| Mar 11, 2021 | After the close | -7.00 | -5.20 | +25.7% |
| Nov 10, 2020 | After the close | -0.80 | -5.40 |
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product…
| -575.0% |
| Aug 13, 2020 | After the close | -0.90 | -30.40 | -3277.8% |
| May 1, 2020 | After the close | -1.00 | -1.00 | 0.0% |
| Mar 11, 2020 | After the close | -0.07 | -0.80 | -1042.9% |
| Nov 5, 2019 | After the close | -24.00 | -20.00 | +16.7% |
| Aug 6, 2019 | After the close | -24.00 | -4.00 | +83.3% |
| May 2, 2019 | After the close | -24.00 | -28.00 | -16.7% |
| Mar 8, 2019 | After the close | -28.80 | -26.00 | +9.7% |
| Nov 1, 2018 | After the close | -30.80 | -30.00 | +2.6% |
| Aug 1, 2018 | After the close | -40.00 | -30.00 | +25.0% |
| May 2, 2018 | After the close | -34.67 | -34.00 | +1.9% |
| Mar 7, 2018 | After the close | -33.67 | -30.00 | +10.9% |